Stay updated with breaking news from Trappsol Cyclo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report)’s stock price fell 1.1% during mid-day trading on Friday . The stock traded as low as $1.81 and last traded at $1.88. 26,821 shares changed hands during trading, a decline of 76% from the average session volume of 111,431 shares. The stock had previously closed at $1.90. […]
Argenx (NASDAQ:ARGX – Get Free Report) and Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership. Institutional & Insider Ownership 52.8% of argenx shares are […]
(RTTNews) - Cyclo Therapeutics, Inc. (CYTH), a clinical-stage biotechnology company, announced on Monday that it has received a Notice of Allowanc...
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 331,200 shares, an increase of 83.3% from the December 15th total of 180,700 shares. Currently, 3.1% of the company’s stock are short sold. […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) saw a large increase in short interest in November. As of November 15th, there was short interest totalling 223,000 shares, an increase of 76.4% from the October 31st total of 126,400 shares. Currently, 2.6% of the company’s shares are sold short. Based on an average daily trading […]